Cargando…

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector

Attenuated vaccine strains of lumpy skin disease virus (LSDV) have become increasingly popular as recombinant vaccine vectors, to target both LSDV, as well as other pathogens, including human infectious agents. Historically, these vaccine strains and recombinants were generated in primary (lamb) tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Diepen, Michiel, Chapman, Rosamund, Douglass, Nicola, Whittle, Leah, Chineka, Nicole, Galant, Shireen, Cotchobos, Christian, Suzuki, Akiko, Williamson, Anna-Lise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539341/ https://www.ncbi.nlm.nih.gov/pubmed/34696239 http://dx.doi.org/10.3390/vaccines9101131

Ejemplares similares

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Chapman, Ros, et al.
Publicado: (2021)

A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV)
por: Shen, Yen-Ju, et al.
Publicado: (2011)

Lumpy Skin Disease—An Emerging Cattle Disease in Europe and Asia
por: Whittle, Leah, et al.
Publicado: (2023)

Influence of the Viral Superoxide Dismutase (SOD) Homologue on Lumpy Skin Disease Virus (LSDV) Growth, Histopathology and Pathogenicity
por: Douglass, Nicola, et al.
Publicado: (2020)

LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
por: de Moor, Warren R. J., et al.
Publicado: (2023)

Development of a dual vaccine against East Coast fever and lumpy skin disease
por: Whittle, Leah, et al.
Publicado: (2023)

Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus
por: van Diepen, Michiel T., et al.
Publicado: (2019)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
por: Chapman, Rosamund, et al.
Publicado: (2020)

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines
por: Chapman, Rosamund, et al.
Publicado: (2023)

Potential mechanical transmission of Lumpy skin disease virus (LSDV) by the stable fly (Stomoxys calcitrans) through regurgitation and defecation
por: Paslaru, Anca I., et al.
Publicado: (2020)

Recombinant LSDV Strains in Asia: Vaccine Spillover or Natural Emergence?
por: Vandenbussche, Frank, et al.
Publicado: (2022)

Molecular characterization of lumpy skin disease virus (LSDV) emerged in Bangladesh reveals unique genetic features compared to contemporary field strains
por: Badhy, Shukes Chandra, et al.
Publicado: (2021)

Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice
por: Whittle, Leah, et al.
Publicado: (2022)

Phylogenetic Analysis of South African Bovine Leukaemia Virus (BLV) Isolates
por: Suzuki, Akiko, et al.
Publicado: (2020)

Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana
por: Margolin, Emmanuel, et al.
Publicado: (2021)

The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF)
por: Douglass, Nicola, et al.
Publicado: (2021)

Characterization and Immunogenicity of HIV Envelope gp140 Zera(®) Tagged Antigens
por: Ximba, Phindile, et al.
Publicado: (2020)

Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
por: Chapman, Rosamund, et al.
Publicado: (2013)

Correction: Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
por: Chapman, Rosamund, et al.
Publicado: (2013)

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen
por: Chapman, Rosamund, et al.
Publicado: (2014)

The Importance of Quality Control of LSDV Live Attenuated Vaccines for Its Safe Application in the Field
por: Haegeman, Andy, et al.
Publicado: (2021)

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256
por: van Diepen, Michiel T., et al.
Publicado: (2018)

Non-vector-borne transmission of lumpy skin disease virus
por: Aleksandr, Kononov, et al.
Publicado: (2020)

Protection of Cattle Elicited Using a Bivalent Lumpy Skin Disease Virus-Vectored Recombinant Rift Valley Fever Vaccine
por: Wallace, David B., et al.
Publicado: (2020)

Validation of TaqMan-Based Assays for Specific Detection and Differentiation of Wild-Type and Neethling Vaccine Strains of LSDV
por: Vidanović, Dejan, et al.
Publicado: (2021)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
por: Margolin, Emmanuel, et al.
Publicado: (2019)

Risk of introduction of lumpy skin disease in France by the import of vectors in animal trucks
por: Saegerman, Claude, et al.
Publicado: (2018)

Analysis and insights into recombination signals in lumpy skin disease virus recovered in the field
por: Sprygin, Alexander, et al.
Publicado: (2018)

Comparison of Gross Pathology between Classical and Recombinant Lumpy Skin Disease Viruses
por: Shumilova, Irina, et al.
Publicado: (2023)

Actinomycosis (Lumpy Jaw)
por: Hickman, R. W.
Publicado: (1892)

Effect of thioredoxin on the immunogenicity of the recombinant P32 protein of lumpy skin disease virus
por: Tursunov, Kanat, et al.
Publicado: (2022)

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa
por: Margolin, Emmanuel, et al.
Publicado: (2020)

A Lumpy Bumpy Liver
por: Pawar, Sunil V., et al.
Publicado: (2015)

Lumpy skin disease in Kazakhstan
por: Orynbayev, Mukhit B., et al.
Publicado: (2021)

Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease
por: Sprygin, Alexander, et al.
Publicado: (2020)

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation
por: Chapman, Rosamund, et al.
Publicado: (2019)

Epidemic of lumpy skin disease in Pakistan
por: Khatri, Govinda, et al.
Publicado: (2023)

Rapid Spread and Genetic Characterisation of a Recently Emerged Recombinant Lumpy Skin Disease Virus in Thailand
por: Suwankitwat, Nutthakarn, et al.
Publicado: (2022)

Masquerading case of a lumpy bumpy face
por: Dazé, Robert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bqbiqirso0cm0bguu25j79avrc